Emyria Ltd (ASX:EMD) MD Michael Winlo introduces Proactive to the company’s new independent non-executive chairman Greg Hutchinson. Hutchinson will help bolster EMD’s innovative mental health research and development programs. As CEO of Sonic HealthPlus for the past 13 years and deputy CEO of S&P/ASX 100 company Sonic Clinical Services, he has significant expertise in scaling frontline health services and research programs.
"Joining Emyria is an incredible opportunity to lead in a groundbreaking area of mental health treatment – underpinned by world-class research infrastructure and processes," Hutchinson said. "With Australia's landmark decision to legalise MDMA and psilocybin for therapeutic use, we are at the forefront of a major healthcare revolution."
Contact DetailsProactive Investors
Jonathan Jackson
+61 413 713 744
